Skip directly to searchSkip directly to the site navigationSkip directly to the page's main content

Deaths due to Cervical Cancer by Year, New Jersey and the United States, 2000 to 2020

Indicator Report Data View Options

Why Is This Important?

Cervical cancer is highly preventable because screening tests and a vaccine to prevent human papillomavirus (HPV) infections are available. When cervical cancer is found early, it is highly treatable and associated with long survival and good quality of life.[ ^1^]


Deaths with malignant neoplasm (cancer) of the cervix uteri as the underlying cause of death ICD-10 code: C53

Data Notes

  • Data have been age-adjusted to the U.S. 2000 standard population.
  • This is Healthy New Jersey 2020 (HNJ2020) Objective CA-4.

Data Sources

How the Measure is Calculated

  • Numerator:

    Number of deaths among females due to cancer of the uterine cervix
  • Denominator:

    Estimated number of females in the population

Related Health Objectives and Indicators

Relevant Population Characteristics

Sociodemographic characteristics associated with delays in follow-up care for abnormal cervical cancer screening results in New Jersey include nativity [ (Tsui et al., 2019.)].

Health Care System Factors

Women who have had an HPV vaccine still need to undergo cervical cancer screening because the vaccine does not fully protect against all the strains of the virus and other risk factors that can cause cervical cancer. See [] for cervical cancer screening recommendations.

Related Health Care System Factors Indicators:

Related Risk Factors Indicators:

Related Health Status Outcomes Indicators:

Health Topic Pages Related to: Deaths due to Cervical Cancer

Indicator Data Last Updated On 04/10/2023, Published on 05/30/2024
Cancer Epidemiology Services, New Jersey Department of Health, PO Box 369, Trenton, NJ 08625-0369, e-mail: (